Cargando…
Fasting-mimicking diet synergizes with ferroptosis against quiescent, chemotherapy-resistant cells
BACKGROUND: More than ten randomized clinical trials are being tested to evaluate the efficacy, effectiveness and safety of a fasting-mimicking diet (FMD) combined with different antitumor agents. METHODS: UMI-mRNA sequencing, Cell-cycle analysis, Label retention, metabolomics, Multilabeling et al....
Autores principales: | Liu, Xiaoxia, Peng, Shaoyong, Tang, Guannan, Xu, Gaopo, Xie, Yumo, Shen, Dingcheng, Zhu, Mingxuan, Huang, Yaoyi, Wang, Xiaolin, Yu, Huichuan, Huang, Meijin, Luo, Yanxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996234/ https://www.ncbi.nlm.nih.gov/pubmed/36863257 http://dx.doi.org/10.1016/j.ebiom.2023.104496 |
Ejemplares similares
-
RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A‐YTHDF2‐dependent manner
por: Shen, Dingcheng, et al.
Publicado: (2023) -
Current treatment and surveillance modalities are not sufficient for advanced stage III colon cancer: Result from a multicenter cohort analysis
por: Li, Juan, et al.
Publicado: (2021) -
Aberrant methylation in neurofunctional gene serves as a hallmark of tumorigenesis and progression in colorectal cancer
por: Li, Xuan, et al.
Publicado: (2023) -
Radiological lymph‐node size improves the prognostic value of systemic inflammation index in rectal cancer with pathologically negative nodes
por: Peng, Shaoyong, et al.
Publicado: (2023) -
Clinical spectrum of rectal cancer identifies hallmarks of early‐onset patients and next‐generation treatment strategies
por: Shen, Dingcheng, et al.
Publicado: (2022)